PMC21 USING GROWTH IN THE COST-EFFECTIVENESS THRESHOLD TO INFORM THE DIFFERENTIAL BETWEEN THE DISCOUNT RATES ON COSTS AND HEALTH EFFECTS- REASON TO BE CAUTIOUS?
Abstract
Authors
J OMahony
J OMahony
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now